Drug Watch

Latest News

The Psychiatric Pipeline in Review: Quarter 2, 2025
The Psychiatric Pipeline in Review: Quarter 2, 2025

July 7th 2025

What disease states are most prominently featured in recent research? Learn more in this exclusive article.

psychedelic
Positive Results From the Phase 2b Study of BPL-003 in Patients With Treatment-Resistant Depression

July 1st 2025

child ADHD
FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

July 1st 2025

pharma
June in Review: Updates on the Psychiatric Treatment Pipeline

June 30th 2025

depression
ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial

June 27th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.